SP
DXCM icon

Symmetry Partners’s DexCom DXCM Stock Holding History

Symmetry Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,737
Closed -$988K – 301
2026
Q1 		$988K Buy
15,737
+173
+1% +$12K 0.06% 74
2025
Q4 		$1.03M Buy
15,564
+327
+2% +$21.1K 0.06% 69
2025
Q3 		$1.03M Buy
15,237
+13
+0.1% +$1.03K 0.11% 64
2025
Q2 		$1.33M Buy
15,224
+453
+3% +$35.5K 0.16% 55
2025
Q1 		$1.01M Buy
14,771
+21
+0.1% +$1.71K 0.14% 61
2024
Q4 		$1.15M Sell
14,750
-14
-0.1% -$1.04K 0.16% 57
2024
Q3 		$990K Buy
+14,764
New +$1.21M 0.23% 47
2024
Q2 		– Sell
-1,454
Closed -$202K – 523
2024
Q1 		$202K Buy
+1,454
New +$183K 0.02% 530
2023
Q3 		– Sell
-1,882
Closed -$242K – 539
2023
Q2 		$242K Hold
1,882
– – 0.01% 512
2023
Q1 		$219K Hold
1,882
– – 0.01% 519
2022
Q4 		$213K Buy
+1,882
New +$207K 0.01% 524
2022
Q3 		– Sell
-3,536
Closed -$264K – 553
2022
Q2 		$264K Hold
3,536
– – 0.02% 485
2022
Q1 		$452K Hold
3,536
– – 0.03% 384
2021
Q4 		$475K Hold
3,536
– – 0.03% 408
2021
Q3 		$478K Hold
3,536
– – 0.03% 423
2021
Q2 		$377K Buy
3,536
+680
+24% +$65.3K 0.03% 524
2021
Q1 		$257K Sell
2,856
-1,544
-35% -$145K 0.02% 589
2020
Q4 		$407K Sell
4,400
-532
-11% -$47.5K 0.03% 439
2020
Q3 		$508K Buy
4,932
+2,080
+73% +$217K 0.04% 315
2020
Q2 		$289K Buy
+2,852
New +$255K 0.04% 239
2019
Q2 		– Sell
-11,836
Closed -$352K – 354
2019
Q1 		$352K Buy
11,836
+8,320
+237% +$292K 0.06% 214
2018
Q4 		$105K Buy
+3,516
New +$112K 0.03% 328

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Symmetry Partners's DXCM Position: Q2 2026 in Review

Symmetry Partners sold out of DexCom (DXCM) in Q2 2026, closing a stake of 15,737 shares — an estimated $988K sold.

Symmetry Partners first reported a position in DXCM in Q4 2018 and held it in 22 quarters. The position peaked at $1.33M in Q2 2025. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Symmetry Partners reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Symmetry Partners sold 15,737 DexCom shares in Q2 2026, an estimated $988K.
  • Symmetry Partners first reported a position in DexCom in Q4 2018 and held it in 22 quarters.
  • Symmetry Partners's DexCom position peaked at $1.33M in Q2 2025.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Symmetry Partners's 13F filing for Q2 2026, filed 23 Jul 2026.